Biomatrix plans to sell Synvisc direct on Television
This article was originally published in Clinica
Biomatrix' US marketing partner, Wyeth-Ayerst Laboratories, will begin showing a television advertisement for the viscosupplementation product, Synvisc, in January to raise patients' awareness of the product and persuade them to seek treatment for arthritis-associated knee pain. The campaign may be the first of its kind for an FDA-approved medical device.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.